Kiniksa Pharmaceuticals H-1B salaries (2025)
Yes — Kiniksa Pharmaceuticals sponsors H-1B workers. Across 2 certified Labor Condition Applications, the median offered base wage is $239,965. Every figure below comes straight from the employer's own filings with the U.S. Department of Labor.
Kiniksa Pharmaceuticals filed 2 certified H-1B labor condition applications across 1 state between Mar 2025 and May 2025. The median offered base wage was $239,965.
- Median offered wage
- $239,965
- Certified filings
- 2
- Work locations
- 1 states
- Distinct roles
- 2
Most-filed roles at Kiniksa Pharmaceuticals
| Role | Filings | Median wage |
|---|---|---|
| Associate Director, Clinical Quality Assurance | 1 | $189,930 |
| Senior Director, Global Medical Safety | 1 | $290,000 |
Wage-level distribution
DOL prevailing-wage levels reflect the seniority the employer certified, from Level I (entry) to Level IV (fully competent).
| Level | Filings | Median wage |
|---|---|---|
| Level IV — fully competent | 2 | $239,965 |
Where Kiniksa Pharmaceuticals hires
| State | Filings | Median wage |
|---|---|---|
| Massachusetts | 2 | $239,965 |
Recent certified filings
| Job title | Location | Wage | Level | Decided |
|---|---|---|---|---|
| Associate Director, Clinical Quality Assurance | Lexington, Massachusetts | $189,930 | IV | May 2025 |
| Senior Director, Global Medical Safety | Lexington, Massachusetts | $290,000 | IV | Mar 2025 |
Source: U.S. Department of Labor OFLC certified Labor Condition Applications (H-1B, H-1B1, E-3), public disclosure data. Wages are employer-offered base pay and exclude bonuses, equity, and other compensation. Denied and withdrawn filings are excluded. Figures reflect filings decided Mar 2025–May 2025.
Compare across employers
For general educational purposes, not career or financial advice. Wages are employer-offered base pay from certified DOL LCA records and may differ from total compensation.